TCGA RNA sequencing data from GBM patients also showed that high CCR7 expression was associated with reduced survival in these patients (overall survival: 11.2 versus 15.4 months for high and low expression respectively, Fig. 1d). Here, CCR7 is linked to glioblastoma.